Halliburton (HAL.US) Q4 revenue decreased by 2.4% year-on-year, falling short of expectations.
Halliburton's total revenue in Q4 was $5.6 billion, down 2.4% year-on-year, which was $30 million lower than market expectations.
On January 22nd pre-market, energy products and services supplier Halliburton (HAL.US) announced its fourth-quarter performance for the year 2024. The financial report shows that Halliburton's Q4 total revenue was $5.6 billion, a 2.4% decrease year-over-year, lower than market expectations by $30 million; net profit was $615 million, compared to $661 million in the same period last year; basic and diluted earnings per share were $0.70, compared to $0.74 in the same period last year; non-GAAP earnings per share were $0.70, exceeding market expectations by $0.01.
In terms of business segments, completion and production business revenue was $3.2 billion, a 4% decrease compared to the previous quarter; drilling and evaluation business revenue was $2.4 billion, remaining flat compared to the previous quarter.
In the fourth quarter, the company's operating cash flow was $1.5 billion, with free cash flow of $1.1 billion.
In the fourth quarter, Halliburton repurchased approximately $309 million worth of common stock and repaid approximately $100 million of debt through multiple preferred notes.
 Related Articles 

YUM CHINA (09987) will distribute a third quarter dividend of $0.24 per share on December 23rd.

YUM CHINA (09987) The operating profit in the third quarter increased by 8% year-on-year to 400 million US dollars.

On November 4th, ANTON OILFIELD (03337) repurchased 4.75 million shares for HKD 4.9989 million.
YUM CHINA (09987) will distribute a third quarter dividend of $0.24 per share on December 23rd.

YUM CHINA (09987) The operating profit in the third quarter increased by 8% year-on-year to 400 million US dollars.

On November 4th, ANTON OILFIELD (03337) repurchased 4.75 million shares for HKD 4.9989 million.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


